Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8676 |
High Similarity |
NPD2674 |
Phase 3 |
0.8611 |
High Similarity |
NPD4123 |
Phase 3 |
0.8521 |
High Similarity |
NPD3060 |
Approved |
0.8467 |
Intermediate Similarity |
NPD3145 |
Approved |
0.8467 |
Intermediate Similarity |
NPD3144 |
Approved |
0.8322 |
Intermediate Similarity |
NPD4678 |
Approved |
0.8322 |
Intermediate Similarity |
NPD4675 |
Approved |
0.8299 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD4237 |
Approved |
0.8264 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.8261 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8207 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.8085 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.8082 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.8056 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.8039 |
Intermediate Similarity |
NPD2977 |
Approved |
0.8039 |
Intermediate Similarity |
NPD2978 |
Approved |
0.8039 |
Intermediate Similarity |
NPD5773 |
Approved |
0.8039 |
Intermediate Similarity |
NPD5772 |
Approved |
0.8014 |
Intermediate Similarity |
NPD4162 |
Approved |
0.8 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7929 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7923 |
Intermediate Similarity |
NPD228 |
Approved |
0.7905 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7832 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7832 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7832 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7826 |
Intermediate Similarity |
NPD3676 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7785 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD4739 |
Approved |
0.7742 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7724 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7724 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7712 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7712 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7698 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD52 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7664 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7664 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7651 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD839 |
Approved |
0.7639 |
Intermediate Similarity |
NPD840 |
Approved |
0.7626 |
Intermediate Similarity |
NPD2337 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD9622 |
Approved |
0.7571 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7551 |
Intermediate Similarity |
NPD6895 |
Approved |
0.755 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7536 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7536 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7535 |
Intermediate Similarity |
NPD9619 |
Approved |
0.7535 |
Intermediate Similarity |
NPD9620 |
Approved |
0.7535 |
Intermediate Similarity |
NPD9621 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7465 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7465 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7448 |
Intermediate Similarity |
NPD597 |
Approved |
0.7448 |
Intermediate Similarity |
NPD601 |
Approved |
0.7448 |
Intermediate Similarity |
NPD598 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7431 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD3532 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3531 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3530 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1132 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1136 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1130 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7386 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD4993 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD9377 |
Approved |
0.7333 |
Intermediate Similarity |
NPD9379 |
Approved |
0.7329 |
Intermediate Similarity |
NPD3056 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.729 |
Intermediate Similarity |
NPD3985 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD7477 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD27 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2489 |
Approved |
0.726 |
Intermediate Similarity |
NPD3179 |
Approved |
0.726 |
Intermediate Similarity |
NPD3180 |
Approved |
0.726 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1024 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD2562 |
Approved |
0.7254 |
Intermediate Similarity |
NPD2561 |
Approved |
0.725 |
Intermediate Similarity |
NPD7089 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1772 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD817 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2157 |
Approved |
0.7248 |
Intermediate Similarity |
NPD823 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD1712 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1048 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD821 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4659 |
Approved |
0.72 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5238 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1423 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3122 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2568 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3778 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1044 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD7596 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD9380 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD3111 |
Phase 1 |
0.7103 |
Intermediate Similarity |
NPD4103 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD4104 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD2821 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7131 |
Phase 3 |
0.7089
|
Intermediate Similarity |
NPD6031 |
Approved |